In Silico and In Vitro Anticoagulant Activity Detection of Quercetin, Rutin, and Troxerutin as New Potential Inhibitors of Factor Xa
sabbagh, G., Al-Beik, L., Hadid, I. (2023). In Silico and In Vitro Anticoagulant Activity Detection of Quercetin, Rutin, and Troxerutin as New Potential Inhibitors of Factor Xa. EKB Journal Management System, 66(2), 151-166. doi: 10.21608/ejchem.2022.140123.6144
Ghalia M sabbagh; Lara M Al-Beik; Ibrahim Hadid. "In Silico and In Vitro Anticoagulant Activity Detection of Quercetin, Rutin, and Troxerutin as New Potential Inhibitors of Factor Xa". EKB Journal Management System, 66, 2, 2023, 151-166. doi: 10.21608/ejchem.2022.140123.6144
sabbagh, G., Al-Beik, L., Hadid, I. (2023). 'In Silico and In Vitro Anticoagulant Activity Detection of Quercetin, Rutin, and Troxerutin as New Potential Inhibitors of Factor Xa', EKB Journal Management System, 66(2), pp. 151-166. doi: 10.21608/ejchem.2022.140123.6144
sabbagh, G., Al-Beik, L., Hadid, I. In Silico and In Vitro Anticoagulant Activity Detection of Quercetin, Rutin, and Troxerutin as New Potential Inhibitors of Factor Xa. EKB Journal Management System, 2023; 66(2): 151-166. doi: 10.21608/ejchem.2022.140123.6144

In Silico and In Vitro Anticoagulant Activity Detection of Quercetin, Rutin, and Troxerutin as New Potential Inhibitors of Factor Xa

Egyptian Journal of Chemistry
Volume 66, Issue 2, February 2023, Page 151-166  XML PDF (1.25 MB)
Document Type: Original Article
DOI: 10.21608/ejchem.2022.140123.6144
View on SCiNiTO View on SCiNiTO
Authors
Ghalia M sabbagh email orcid 1; Lara M Al-Beik2; Ibrahim Hadid3
1Department of Pharmaceutical Chemistry and Quality Control, Faculty of Pharmacy, Aleppo University, Syria
2Department of Pharmaceutical Chemistry and Quality Control, Faculty of Pharmacy, Aleppo University, Syria.
3Department of Surgery, Faculty of Medicine, Aleppo University, Syria
Abstract
Factor Xa is an important target for the development of new anticoagulants. The present study aims to examine the effect of three compounds (Quercetin and its derivatives Rutin and Troxerutin) in comparison with Rivaroxaban on activated Human Clotting factor X (PDB ID: 2w26). Molecular docking was performed using iGemDock v2.1 software to predict their anti-activating factor X activity and Autodock vina software to check the bonds formed. Next, the in vitro biological effects on both PT and aPTT coagulation time were studied. Troxerutin and Rutin showed the best interaction values with 2w26 enzyme, and the binding energy was [(-185.743 kcal/mol) and (-178.034 kcal/mol)], respectively, using iGemDock; While the binding energy of Rivaroxaban was (-149.661 kcal/mol). The results of the in vitro study showed that the studied compounds have an effect in prolonging PT, aPTT compared to both negative and positive control. However, Troxerutin gave the highest prolongation of the evaluated clotting times, consistent with the in silico study the results
Keywords
Anticoagulants; Factor Xa; Molecular docking; Rivaroxaban; Troxerutin
Statistics
Article View: 540
PDF Download: 324